Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor - Yardley, D A; Ismail-Khan, R R; Melichar, B (J Clin Oncol, 2013)